Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Other financing activities (2017 - 2020)

Historic Other financing activities for Rocket Pharmaceuticals (RCKT) over the last 2 years, with Q2 2020 value amounting to $139000.0.

  • Rocket Pharmaceuticals' Other financing activities changed N/A to $139000.0 in Q2 2020 from the same period last year, while for Mar 2021 it was $139000.0, marking a year-over-year increase of 4183.67%. This contributed to the annual value of $237000.0 for FY2020, which is N/A changed from last year.
  • Latest data reveals that Rocket Pharmaceuticals reported Other financing activities of $139000.0 as of Q2 2020.
  • Rocket Pharmaceuticals' 5-year Other financing activities high stood at $139000.0 for Q2 2020, and its period low was -$3.2 million during Q4 2017.